Tigermed repurchases 3.07 million A-shares for RMB121.70 million, treasury stock rises to 10.51 million

Bulletin Express

06/11

Hangzhou Tigermed Consulting Co., Ltd. (Tigermed) disclosed that on 11 June 2026 it bought back 3.07 million A-shares on the Shenzhen Stock Exchange, spending RMB121.70 million in total. The shares were repurchased at prices ranging from RMB39.13 to RMB39.96 per share, with a volume-weighted average price of RMB39.61.

Prior to the transaction (as of 10 June 2026), Tigermed had 730.47 million issued shares (excluding treasury shares) and 7.43 million treasury shares, for a total of 737.90 million shares in issue. The latest buyback reduced the number of issued shares (excluding treasury shares) by 0.42% to 727.39 million and lifted the treasury-share balance to 10.51 million. The overall number of shares in issue remains unchanged at 737.90 million.

The company confirmed that the repurchase complied with both Hong Kong Stock Exchange Main Board Rules and the relevant Shenzhen Stock Exchange regulations.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1139502487"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1139502487\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1139502487?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-11 19:41","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1139502487","market":"us","top_or_hot":-1,"title":"Tigermed repurchases 3.07 million A-shares for RMB121.70 million, treasury stock rises to 10.51 million","media":"Bulletin Express","content":"<p>Hangzhou Tigermed Consulting Co., Ltd. (Tigermed) disclosed that on 11 June 2026 it bought back 3.07 million A-shares on the Shenzhen Stock Exchange, spending RMB121.70 million in total. The shares were repurchased at prices ranging from RMB39.13 to RMB39.96 per share, with a volume-weighted average price of RMB39.61.</p>\n<p>Prior to the transaction (as of 10 June 2026), Tigermed had 730.47 million issued shares (excluding treasury shares) and 7.43 million treasury shares, for a total of 737.90 million shares in issue. The latest buyback reduced the number of issued shares (excluding treasury shares) by 0.42% to 727.39 million and lifted the treasury-share balance to 10.51 million. The overall number of shares in issue remains unchanged at 737.90 million.</p>\n<p>The company confirmed that the repurchase complied with both Hong Kong Stock Exchange Main Board Rules and the relevant Shenzhen Stock Exchange regulations.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tigermed repurchases 3.07 million A-shares for RMB121.70 million, treasury stock rises to 10.51 million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTigermed repurchases 3.07 million A-shares for RMB121.70 million, treasury stock rises to 10.51 million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-11 19:41</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hangzhou Tigermed Consulting Co., Ltd. (Tigermed) disclosed that on 11 June 2026 it bought back 3.07 million A-shares on the Shenzhen Stock Exchange, spending RMB121.70 million in total. The shares were repurchased at prices ranging from RMB39.13 to RMB39.96 per share, with a volume-weighted average price of RMB39.61.</p>\n<p>Prior to the transaction (as of 10 June 2026), Tigermed had 730.47 million issued shares (excluding treasury shares) and 7.43 million treasury shares, for a total of 737.90 million shares in issue. The latest buyback reduced the number of issued shares (excluding treasury shares) by 0.42% to 727.39 million and lifted the treasury-share balance to 10.51 million. The overall number of shares in issue remains unchanged at 737.90 million.</p>\n<p>The company confirmed that the repurchase complied with both Hong Kong Stock Exchange Main Board Rules and the relevant Shenzhen Stock Exchange regulations.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03347","symbol_name":"泰格医药","start_time":0,"source_url":"","article_id":"1139502487","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1139502487","pubTimestamp":1781178094,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Hangzhou Tigermed Consulting Co., Ltd. (Tigermed) disclosed that on 11 June 2026 it bought back 3.07 million A-shares on the Shenzhen Stock Exchange, spending RMB121.70 million in total. The shares...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03347":"泰格医药"},"translate_title":"泰格医药以1.217亿元回购307万股A股库存股升至1051万股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03347":1},"content_text":"Hangzhou Tigermed Consulting Co., Ltd. (Tigermed) disclosed that on 11 June 2026 it bought back 3.07 million A-shares on the Shenzhen Stock Exchange, spending RMB121.70 million in total. The shares were repurchased at prices ranging from RMB39.13 to RMB39.96 per share, with a volume-weighted average price of RMB39.61.\nPrior to the transaction (as of 10 June 2026), Tigermed had 730.47 million issued shares (excluding treasury shares) and 7.43 million treasury shares, for a total of 737.90 million shares in issue. The latest buyback reduced the number of issued shares (excluding treasury shares) by 0.42% to 727.39 million and lifted the treasury-share balance to 10.51 million. The overall number of shares in issue remains unchanged at 737.90 million.\nThe company confirmed that the repurchase complied with both Hong Kong Stock Exchange Main Board Rules and the relevant Shenzhen Stock Exchange regulations.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,buyback,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}